| Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma | |
| Vitolo, Umberto; Trneny, Marek; Belada, David; Burke, John M.; Carella, Angelo Michele; Chua, Neil; Abrisqueta, Pau; Demeter, Judit; Flinn, Ian; Hong, Xiaonan | |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 2017 | |
| 卷号 | 35期号:31 |
| ISSN号 | 0732-183X |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3617772 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Vitolo, Umberto,Trneny, Marek,Belada, David,et al. Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma[J]. JOURNAL OF CLINICAL ONCOLOGY,2017,35(31). |
| APA | Vitolo, Umberto.,Trneny, Marek.,Belada, David.,Burke, John M..,Carella, Angelo Michele.,...&Sehn, Laurie H..(2017).Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma.JOURNAL OF CLINICAL ONCOLOGY,35(31). |
| MLA | Vitolo, Umberto,et al."Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma".JOURNAL OF CLINICAL ONCOLOGY 35.31(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论